Last March, the American Civil Liberties Union and the Public Patent Base sued Myriad Genetics Inc., the University of Utah Research Foundation and the U.S. Patent and Trademark Office in U.S. District Court in Manhattan. The ACLU and the patent base state Myriad’s refusal to permit the patents broadly offers meant that females who fear they might be at risk of breast or ovarian cancers are prevented from having anyone but Myriad consider the genes in question. Throughout a lengthy hearing in a packed courtroom, U.S. District Judge Robert Sweet was asked by attorneys for the plaintiffs to strike down the validity of the patents, while a lawyer for the defendants called for the lawsuit to be tossed toss out. The judge didn’t rule. Christopher Hansen, an ACLU attorney, told Sweet that experts deserved praise but not patents for winning the race to isolate an important portion of the body.Related StoriesTwo Duke weight problems experts' articles come in the November problem of Health AffairsObesity groupings take aim at says that deny protection of weight problems treatment under affordable treatment actThree out of four customers not really covered for evidence-based weight problems treatment servicesAnother recommended reform is always to improve the ‘fairly ineffective and confusing’ program of meals labeling and the imposition of tougher guidelines on food substances and advertising, with self-regulatory codes initially, but progressing to authorities regulation, if needed, to pressure healthier reformulation’s of foods and cuts to processed foods advertisements targeting children.